Ontario Genomics is pleased to announce that our annual Canada SynBio Conference is going virtual! This national conference, now in its third year, will explore emerging themes in engineering biology through a series of engaging and interactive webinars.

This page is updated regularly, do visit to stay up-to-date about future events and webinars or follow us on Twitter.

Next Generation Biomanufacturing for the Bio-Revolution: An International Opportunity

Thursday, December 3, 2020 | 2:00 pm - 3:30 pm EST

Ontario Genomics is pleased to partner with Policy Horizons Canada and SynBio Canada as part of the Canada SynBio 2020 Canada’s Bio-Revolution Webinar Series. This panel discussion entitled "Next Generation Biomanufacturing for the Bio-Revolution: An International Opportunity" will examine engineering biology-driven manufacturing opportunities from an international perspective. Many leading G20 jurisdictions are already prioritizing engineering biology through significant investments into public-private partnerships and industry. This panel will specifically explore initiatives and strategies in the USA, UK, and Canada.

This much-needed conversation will bring together diverse voices and perspectives from across the value chains of leading experts - researchers, industry, funders and advocates, to generate collaboration and amplify new ideas.


Discussion topics include:

  • The biomanufacturing opportunity and challenges across jurisdictions

  • The impact on and opportunities for traditional economic sectors and industries

  • The convergence of technologies that are enabling innovations, commercialization, job creation, and economic growth

  • Opportunities for international collaboration

  • Impact of the pandemic on local supply chains

  • Power of biomanufacturing and engineering biology to address climate change and a greener economy through low carbon emissions


  • Moderated by Dr. Bettina Hamelin, President & CEO, Ontario Genomics and Chair, National Engineering Biology Steering Committee

  • Dr. Aaron Dulgar-Tulloch, Global Head of Research and Development, Director of Cell and Gene Therapy, Cytiva (formerly GE Life Sciences), Canada

  • Dr. Doug Friedman, CEO, BioMADE & EBRC, USA

  • Pari Johnston, Vice President, Genome Canada, Canada

  • Dr. Kirk Malone, Director of Commercialization, UK Future Biomanufacturing Research Hub (Future BRH), UK

  • Dr. Renee Wegrzyn, Vice President Business Development, Gingko Bioworks, USA


If you have a question please contact us at

661 University Avenue, Suite 490, Toronto, ON M5G 1M1  |  416-977-9582

©2020 by CAN-DESyNe   |